Collins Cooper C. - Net Worth and Insider Trading
Collins Cooper C. Net Worth
The estimated net worth of Collins Cooper C. is at least $109,508 dollars as of 2024-05-18. Collins Cooper C. is the Director of TherapeuticsMD Inc and owns about 44,737 shares of TherapeuticsMD Inc (TXMD) stock worth over $99,316. Collins Cooper C. is also the Chief Strategic Officer of Pernix Therapeutics Holdings Inc and owns about 352,657 shares of Pernix Therapeutics Holdings Inc (PTXTQ) stock worth over $10,192. Details can be seen in Collins Cooper C.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Collins Cooper C. has not made any transactions after 2021-11-18 and currently still holds the listed stock(s).
Transaction Summary of Collins Cooper C.
Collins Cooper C. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Collins Cooper C. owns 2 companies in total, including TherapeuticsMD Inc (TXMD) , and Pernix Therapeutics Holdings Inc (PTXTQ) .
Click here to see the complete history of Collins Cooper C.’s form 4 insider trades.
Insider Ownership Summary of Collins Cooper C.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TXMD | TherapeuticsMD Inc | 2021-11-18 | director |
| PTXTQ | Pernix Therapeutics Holdings Inc | 2014-04-02 | Chief Strategic Officer |
Collins Cooper C. Latest Holdings Summary
Collins Cooper C. currently owns a total of 2 stocks. Among these stocks, Collins Cooper C. owns 44,737 shares of TherapeuticsMD Inc (TXMD) as of November 18, 2021, with a value of $99,316 and a weighting of 90.69%. Collins Cooper C. also owns 352,657 shares of Pernix Therapeutics Holdings Inc (PTXTQ) as of April 2, 2014, with a value of $10,192 and a weighting of 9.31%.
Latest Holdings of Collins Cooper C.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TXMD | TherapeuticsMD Inc | 2021-11-18 | 44,737 | 2.22 | 99,316 |
| PTXTQ | Pernix Therapeutics Holdings Inc | 2014-04-02 | 352,657 | 0.03 | 10,192 |
Holding Weightings of Collins Cooper C.
Collins Cooper C. Form 4 Trading Tracker
According to the SEC Form 4 filings, Collins Cooper C. has made a total of 3 transactions in TherapeuticsMD Inc (TXMD) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in TherapeuticsMD Inc is the acquisition of 20,000 shares on November 18, 2021, which cost Collins Cooper C. around $580,000.
According to the SEC Form 4 filings, Collins Cooper C. has made a total of 0 transactions in Pernix Therapeutics Holdings Inc (PTXTQ) over the past 5 years. The most-recent trade in Pernix Therapeutics Holdings Inc is the sale of 9,000 shares on April 2, 2014, which brought Collins Cooper C. around $473,400.
Insider Trading History of Collins Cooper C.
- 1
Collins Cooper C. Trading Performance
GuruFocus tracks the stock performance after each of Collins Cooper C.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Collins Cooper C. is -4.68%. GuruFocus also compares Collins Cooper C.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Collins Cooper C. within 3 months outperforms 2 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Collins Cooper C.'s insider trading performs compared to the benchmark.
Performance of Collins Cooper C.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.38 | | | | | |
| Relative Return to S&P 500(%) | -5.94 | | | | | |
Collins Cooper C. Ownership Network
Collins Cooper C. Owned Company Details
What does TherapeuticsMD Inc do?
Who are the key executives at TherapeuticsMD Inc?
Collins Cooper C. is the director of TherapeuticsMD Inc. Other key executives at TherapeuticsMD Inc include General Counsel Marlan D Walker , Principal Financial Officer Joseph Ziegler , and CAO and VP of Finance Michael C Donegan .
TherapeuticsMD Inc (TXMD) Insider Trades Summary
Over the past 18 months, Collins Cooper C. made no insider transaction in TherapeuticsMD Inc (TXMD). Other recent insider transactions involving TherapeuticsMD Inc (TXMD) include a net sale of 21,960 shares made by Marlan D Walker , a net sale of 3,916 shares made by Michael C Donegan , and a net purchase of 35,238 shares made by Rubric Capital Management Lp .
In summary, during the past 3 months, insiders sold 0 shares of TherapeuticsMD Inc (TXMD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 31,493 shares of TherapeuticsMD Inc (TXMD) were sold and 35,238 shares were bought by its insiders, resulting in a net purchase of 3,745 shares.
TherapeuticsMD Inc (TXMD)'s detailed insider trading history can be found in Insider Trading Tracker table.
TherapeuticsMD Inc Insider Transactions
Collins Cooper C. Mailing Address
Above is the net worth, insider trading, and ownership report for Collins Cooper C.. You might contact Collins Cooper C. via mailing address: 33219 Forest West Drive, Magnolia Tx 77354.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
